Table 1.
Baseline demographic and clinical characteristics for each group.
| Experimental Group (n = 20) |
Control Group (n = 20) |
p Value | |
|---|---|---|---|
| Gender (M; F) | 4M;16F | 4M;16F | 0.999 |
| Age (years) | 55.90 (11.96) | 52.10 (16.03) | 0.401 |
| Weight (kg) | 65.90 (11.96) | 66.90 (11.56) | 0.730 |
| Height (cm) | 163.30 (8.53) | 162.40 (7.79) | 0.790 |
| wVAS | 74.45 (17.34) | 70.94 (23.48) | 0.585 |
| NDI | 12.45 (5.96) | 14.60 (5.44) | 0.231 |
| TSK-11 | 24.20 (5.72) | 24.45 (6.82) | 0.901 |
| DHI | |||
| Severe | 3 (15%) | 2 (10%) | 0.795 |
| Moderate | 10 (50%) | 12 (60%) | |
| Low | 7 (35%) | 6 (30%) |
Abbreviations: M, Male; F, Female; kg, Kilograms; cm, centimeters; wVAS, worst visual analogue scale; NDI, Neck Disabilty Index; TSK-11: Tampa Kinesophobia Scale; DHI, Dizziness Handicap Inventory.